There are many basic errors in this "analytics report". As an example, see your entire Clears Lewy Body section. It's just wrong, some nonsensical. There's no benefit to giving an S1 agonist to an S1-knockout mouse; it doesn't have the receptor. The research you cited didn't give "a weak S1 agonist" to the mice. See what those compounds are (one's an antibiotic). You confirmed what you believed, always a mistake in reading research.
I don't know why Anavex would use this, do you?